RE:RE:Theralase = TLD-1433Agreed Oilminer - in the medium term there are only 3 positive possibilties from Phase II:
That the 5 patients to receive a second treatment at the revised and now allegedly correct doses of light and drug achieve or retain a resultant Complete Response.
That enrolees presently without a confirmed Complete Response are re-categorised as such (these first two categories may overlap).
That the Company apply to Health Canada requesting on compassionate grounds that the 4 enrolees mistakenly removed from the Trial as the result of an ambiguous Clinical Protocol be allowed their second treament. Even if re-inclusion in the Trial were prohibited this would both right a wrong for these patients and restore a sufficient sample to allow an opportunity for the unfair damage done to TLD-1433 by the universal and substantial under-dosing of both drug and light to be redressed.